Switch to:

Agios Pharmaceuticals Inc (AGIO) Ownership Data

Short Interest History (%)

This is the historical short interest of Agios Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest
April 30, 201519.55
April 15, 201516.43
March 31, 201517.75
March 13, 201510.11
February 27, 20159.56
February 13, 201510.3
January 30, 201510.83
January 15, 201510.79
December 31, 201449.41
December 15, 201446.98
November 28, 201441.25
November 14, 201445.05
October 31, 201443.7
October 15, 201445.58
September 30, 201443.39
September 15, 201436.18
August 29, 201436.11
August 15, 201438.24
July 31, 201440.66
July 15, 201434.2
June 30, 201433.16
June 13, 201433.46
May 30, 201428.89
May 15, 201425.03
April 30, 201422.71
April 15, 201423.94
March 31, 201421.05
March 14, 201425.34
February 28, 201428.57
February 14, 201427.7
January 31, 201426.16
January 15, 201428.52
December 31, 201327.18
December 13, 201315.43
November 29, 201314.28
November 15, 201313.12
October 31, 201310.9
October 15, 201310.67
September 30, 201310.39
September 13, 20137.62
August 30, 20136.42
August 15, 20134.73
July 31, 20132.42

Institutional Ownership History (%)

This the Institutional Ownership History of Agios Pharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
February 28, 201490
January 31, 201490
December 31, 201389
November 30, 201336
October 31, 201336
September 30, 201321
August 31, 201314
July 31, 201313

Insider ownership (%)

This is the historical insider ownership of Agios Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
April 30, 20152
March 31, 20152
February 28, 20152
January 31, 20152
November 30, 20141
October 31, 20141
September 30, 20141
August 31, 20141
July 31, 20141
June 30, 20141
May 31, 20141

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Kevin P. StarrDirector184,3860.49%2015-02-19
Dr. Lewis C. Cantley, PhDDirector167,2620.45%2015-05-19
Dr. Marc Tessier-Lavigne, PhDDirector101,0090.27%2013-07-24
John Duncan HiggonsCOO98,8350.26%2015-05-15
Dr. John M. Maraganore,PhDDirector50,1740.13%2015-04-28
Dr. Scott Biller, PhDChief Scientific Officer42,7700.11%2015-03-16
Mr. David P. SchenkeinCEO31,019less than 0.1%2015-04-13
Mr. Robert T. NelsenN/A6,689less than 0.1%2015-05-11
Douglas G. ColeN/A1,861less than 0.1%2014-06-23

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Fidelity Management and Research Company   Premium Plus5,579,2682015-03-3114.960.07526,125,000
Celgene Corp5,242,7042014-12-1615.120.00528,516,990
ARCH Venture Partners3,474,6642014-12-319.370.00389,301,355
Wellington Management Company LLP   Premium Plus3,245,6382015-03-318.700.08306,064,000
Wellington Management Company LLP   Premium Plus3,245,6382015-03-318.700.08306,064,000
Capital World Investors   Premium Plus3,157,1202015-03-318.470.08297,716,000
TRV GP, LLC3,070,0902014-12-318.280.00343,972,884
Flagship Ventures 2007 General Partner LLC   Premium Plus1,930,3692015-03-315.1890.41182,034,000
Bb Biotech AG1,849,9212015-03-314.974.34174,714,300
BB Biotech AG   Premium Plus1,849,9212015-03-314.965.20174,448,000
Vanguard Group, Inc.   Premium Plus1,587,3192015-03-314.260.01149,685,000

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK